DrBishoyFaltas

@FaltasLab

Physician-scientist. Director of research . Gellert Family-John P. Leonard scholar . Husband and father. RTs ≠ endorsements

Manhattan, NY
Vrijeme pridruživanja: veljača 2015.

Tweetovi

Blokirali ste korisnika/cu @FaltasLab

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FaltasLab

  1. Prikvačeni tweet
    5. srp 2019.

    Very proud of the latest paper on the biology of upper tract urothelial carcinoma @NatureCommunications Stay tuned for the Twitter explainer.

    , , i još njih 7
    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    4. velj
    Poništi
  3. proslijedio/la je Tweet

    On we asked experts: “What is the bravest thing we can do about cancer?” Dr. Melissa B. Davis () of wants to find ways to make cancer treatment affordable.

    Poništi
  4. proslijedio/la je Tweet
    prije 21 sat

    Improving the lives of all people with relies on talent and insight from across the globe.

    Poništi
  5. proslijedio/la je Tweet

    Today, we join millions of people all over the world to observe . Please help us help others by sharing this information about bladder cancer, the seventh-most frequently diagnosed cancer in the United States.

    Poništi
  6. proslijedio/la je Tweet
    3. velj

    Dr. R. R. Jeeta et al. investigate the frequency of 5 non-coding mutation hotspots in 302 urothelial bladder cancers (UBCs) and assess their potential for UBC detection and prognostication.

    Poništi
  7. proslijedio/la je Tweet

    “Thank you for saving my life." Tomas Dahl (pictured left) was diagnosed with tonsil cancer and told there was no cure. But after trying the cancer therapy pioneered by the 2018 Medicine Laureates (centre and right), he emerged cancer-free.

    Poništi
  8. proslijedio/la je Tweet
    16. pro 2019.

    Memorial Sloan Kettering is seeking a Chief of the Early Drug Development and Immunotherapy Service, whose mission is to lead the translation of novel cancer therapeutics from the lab to the clinic. Applicants should send a CV and brief statement to eddchiefsearch@mskcc.org.

    Prikaži ovu nit
    Poništi
  9. 2. velj
    Poništi
  10. 2. velj
    Poništi
  11. proslijedio/la je Tweet
    1. velj

    "One of the biggest takeaway messages [from the viral sequences] is that there was a single introduction into humans and then human-to-human spread" on the in

    Poništi
  12. proslijedio/la je Tweet
    31. sij

    Physician interpretation of VUS. Over 75% make recommendations that are not warranted. Support

    Poništi
  13. 1. velj

    I remember bookmarking all my favorite online C1V1=C2V2 and molarity calculators for creating stock solutions from powders 🧪

    Poništi
  14. proslijedio/la je Tweet
    1. velj

    Clinical implications of the trial cabazitaxel vs Abi or Enza in pts previously treated w/ docetaxel & had progression within 12 mths while receiving the alternative inhibitor.

    Poništi
  15. proslijedio/la je Tweet

    Leading up to on February 4, we are highlighting and the Jimmy Fund’s global impact, so that one day, we can all live in a world without cancer. Meet Toni Choueiri, MD:

    Prikaži ovu nit
    Poništi
  16. proslijedio/la je Tweet
    29. sij 2018.

    PI broken record: you only know what experiments are left to do (and even how to prioritize them) once you start writing. Write now. BEFORE you think you’re done collecting data.

    Poništi
  17. 29. sij
    Poništi
  18. 29. sij
    Poništi
  19. proslijedio/la je Tweet
    29. sij

    Antibody-drug conjugates for metastatic urothelial carcinoma & 177Lu-PSMA-617 for progressive mCRPC. and discuss advances in & . on UroToday >

    Poništi
  20. proslijedio/la je Tweet

    So many of our BCAN community members have moving and inspiring stories about why they participate in their local Walk to End Bladder Cancer. We highlight those stories on "Why I Walk Wednesdays." Register to participate in a walk near you:

    Poništi
  21. 27. sij

    Great overview of the evolving treatments of non-muscle invasive bladder cancer by

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·